Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure

Chang How-Yi; Vuong Jeni; Hu Fang; Liberator Paul; Chen Alex; Kretz Cecilia B.; Blain Amy; Hao Li; Retchless Adam C.; Whaley Melissa J.; Anderson Annaliesa S.; Wang Xin

首页> 外文期刊>Journal of Infection >Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure

【24h】

Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure

机译：在NMB疫苗许可之前，脑膜炎球菌疾病中脑膜炎球菌疾病中的脑膜炎疾病疫苗抗原的分布，在NMB疫苗许可证之前

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: Two Neisseria meningitidis serogroup B (NmB) vaccines are licensed in the United States. To estimate their potential coverage, we examined the vaccine antigen diversity among meningococcal isolates prior to vaccine licensure.

机译：目的：两种脑膜炎脑膜血清B（NMB）疫苗在美国许可。为了估计其潜在覆盖，我们在疫苗许可证之前检查了脑膜炎球菌分离物中的疫苗抗原多样性。

著录项

来源
《Journal of Infection》 |2019年第5期|共9页
作者
Chang How-Yi; Vuong Jeni; Hu Fang; Liberator Paul; Chen Alex; Kretz Cecilia B.; Blain Amy; Hao Li; Retchless Adam C.; Whaley Melissa J.; Anderson Annaliesa S.; Wang Xin;
展开▼
作者单位

IHRC Inc Meningitis &

Vaccine Preventable Dis Branch US Ctr Dis Control &

Prevent Atlanta GA USA;

Ctr Dis Control &

Prevent Meningitis &

Vaccine Preventable Dis Branch Atlanta GA 30333 USA;

IHRC Inc Meningitis &

Vaccine Preventable Dis Branch US Ctr Dis Control &

Prevent Atlanta GA USA;

Pfizer Vaccine Res Pearl River NY USA;

Ctr Dis Control &

Prevent Meningitis &

Vaccine Preventable Dis Branch Atlanta GA 30333 USA;

IHRC Inc Meningitis &

Vaccine Preventable Dis Branch US Ctr Dis Control &

Prevent Atlanta GA USA;

IHRC Inc Meningitis &

Vaccine Preventable Dis Branch US Ctr Dis Control &

Prevent Atlanta GA USA;

Pfizer Vaccine Res Pearl River NY USA;

Ctr Dis Control &

Prevent Meningitis &

Vaccine Preventable Dis Branch Atlanta GA 30333 USA;

Ctr Dis Control &

Prevent Meningitis &

Vaccine Preventable Dis Branch Atlanta GA 30333 USA;

Pfizer Vaccine Res Pearl River NY USA;

Ctr Dis Control &

Prevent Meningitis &

Vaccine Preventable Dis Branch Atlanta GA 30333 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
Neisseria meningitidis; Serogroup B; Vaccine antigen; Whole genome sequencing; Genetic diversity;

机译：Neisseria Meningitidis;血清群B;疫苗抗原;全基因组测序;遗传多样性;

相似文献

外文文献
中文文献
专利

1. Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure [J] . Chang How-Yi, Vuong Jeni, Hu Fang, Journal of Infection . 2019,第5期

机译：在NMB疫苗许可之前，脑膜炎球菌疾病中脑膜炎球菌疾病中的脑膜炎疾病疫苗抗原的分布，在NMB疫苗许可证之前
2. Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B [J] . Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, Infection and Drug Resistance . 2019,第3期

机译：B型脑膜炎球菌疫苗，用于预防由B型脑膜炎奈瑟菌引起的侵袭性脑膜炎球菌疾病
3. Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014–2017 [J] . Anna Carannante, Cecilia Fazio, Arianna Neri, PLoS One . 2020,第11期

机译：脑膜炎球菌B疫苗抗原FHBP变异性疾病导致Neisseria Meningitidis B孤立，意大利，2014-2017
4. SYNTHESIS OF A NEISSERIA MENINGITIDIS SEROGROUP Y ANTIGEN FRAGMENT AND ITS 4-FLUORINATED ANALOGUE FOR FULLY SYNTHETIC VACCINE CANDIDATES [C] . S. Neidig, M. Reindl, M. Daum International Carbohydrate Symposium . 2018

机译：用于全合成疫苗候选的Neisseria meningitidis血清群抗原片段的合成抗原片段及其4氟化类似物
5. Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B [O] . Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, 2019

机译：B型脑膜炎球菌疫苗用于预防由B型脑膜炎奈瑟菌引起的侵袭性脑膜炎球菌疾病
6. >Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B [O] . Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, 2019

机译：脑膜炎球菌群B疫苗用于预防侵入性脑膜炎疾病引起的 neisseria meningitidis serogroup b

1. 反证：在非洲亚—撒哈拉巴地区流行性和地方性脑膜炎球菌性脑膜炎现在可由脑膜炎球菌A群荚膜多糖疫苗的常见免疫来防治 [J] . 张伸 . 世界医学杂志 . 2002,第020期

2. 抗多个脑膜炎球菌株的B群脑膜炎球菌疫苗在婴儿中的免疫原性 [J] . 孙芳芳 . 国外医学：预防．诊断．治疗用生物制品分册 . 2002,第6期

3. B群脑膜炎奈瑟菌外膜蛋白NMB0315核酸疫苗的免疫活性和免疫保护作用初步研究 [J] . 李开铭 ,谢梅花 ,余敏君 . 中国免疫学杂志 . 2015,第012期

4. WONCA 研究论文摘要汇编--单针剂C群脑膜炎球菌结合疫苗在婴儿12月龄接种加强剂量疫苗后的免疫原性：开放标签随机对照试验 [J] . . 中国全科医学 . 2015,第015期

5. A+W群脑膜炎球菌外膜囊泡疫苗的临床前免疫原性和功能活性研究及其和现有疫苗的比较 [J] . 房明 . 微生物学免疫学进展 . 2014,第6期

6. A、C群脑膜炎球菌-b型流感嗜血杆菌结合疫苗:一种新联合疫苗应用策略的综述 [C] . 刁连东 ,徐爱强 . 2016年新形势下预防接种问题、对策与展望学术论坛 . 2016

7. B群脑膜炎奈瑟菌NMB0315核酸疫苗与重组蛋白疫苗联合免疫效果初探 [A] . 宋迎春 . 2016

1. 包含脑膜炎奈瑟氏球菌的蛋白质NMB0964的疫苗 [P] . 中国专利： CN102215863B . 2015.04.01

2. 包含脑膜炎奈瑟氏球菌的蛋白质NMB0964的疫苗 [P] . 中国专利： CN102215863A . 2011-10-12

3. Immunogenic composition comprising the lipooligosaccharides (los) of meningococcal strains inmunotipos L2 and L3 neissericas composition that includes; Vaccine; Preparation procedure; andIts use for the Prevention or treatment of diseases caused by one or more serogroups of N. meningitidis. [P] . 外国专利： CL2007001698A1 . 2008-01-18

机译：免疫原性组合物，包括脑膜炎双球菌L2和L3奈瑟球菌的脑膜炎球菌菌株的脂寡糖（los），其包括：疫苗;准备程序;它可用于预防或治疗由一个或多个脑膜炎奈瑟球菌血清群引起的疾病。

4. comprehensive aussenmembranvesikel vaccine against disease caused by neisseria meningitidis serogroup a, i / i, and processes for producing the same [P] . 外国专利： DE60124538D1 . 2006-12-28

机译：预防脑膜炎奈瑟氏球菌血清群a，i // i引起的疾病的综合性奥森膜ranvesikel疫苗及其生产方法

5. OUTER MEMBRANE VESICLE VACCINE AGAINST DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUP A AND PROCESS FOR THE PRODUCTION THEREOF [P] . 外国专利： EP1286696B1 . 2006-11-15

机译：抵抗奈瑟球菌血清群A引起的疾病的外膜囊泡疫苗及其生产方法

相关主题

Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure

摘要

著录项

相似文献

相关主题

期刊订阅